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Abstract
 
The delineation of the in vivo role of GATA-3 in human T cell differentiation is a critical step
in the understanding of molecular mechanisms directing human immune responses. We examined
T cell differentiation and T cell–mediated effector functions in individuals lacking one functional
GATA-3 allele. CD4 T cells from GATA-3
 
 
 
/
 
  
 
individuals expressed significantly reduced levels
of GATA-3, associated with markedly decreased T helper cell (Th)2 frequencies in vivo and in
vitro. Moreover, Th2 cell–mediated effector functions, as assessed by serum levels of Th2-
dependent immunoglobulins (Igs; IgG4, IgE), were dramatically decreased, whereas the Th1-
dependent IgG1 was elevated compared with GATA-3
 
 
 
/
 
  
 
controls. Concordant with these
data, silencing of GATA-3 in GATA-3
 
 
 
/
 
  
 
CD4 T cells with small interfering RNA signifi-
cantly reduced Th2 cell differentiation. Moreover, GATA-3 mRNA levels increased under
Th2-inducing conditions and decreased under Th1-inducing conditions. Taken together, the
data strongly suggest that GATA-3 is an important transcription factor in regulating human
Th2 cell differentiation in vivo.
Key words: Th1/Th2 cells • cellular differentiation • transcription factors • 
T lymphocytes • siRNA
 
Introduction
 
CD4 T cells potentiate cellular or humoral immune re-
sponses through the action of Th1 and Th2 cells, respec-
tively. The molecular mechanisms by which antigenic
stimulation of the T cell receptor and signals derived
from costimulatory molecules integrate to drive the dif-
ferentiation of naive T cell precursors into the Th1 or
Th2 direction has been the focus of intensive research
over recent years. It has become clear that T cell differen-
tiation is a complex process regulated by a network of
transcription factors (1). It appears, however, that the
master transcription factor in the Th1/Th2 decision is
GATA-3. GATA-3 is expressed in naive T cells and is
strongly up-regulated during Th2 development, but sub-
sides to a minimal level during in vitro Th1 differentiation
(2). Ectopic expression of GATA-3 induces Th2-specific
cytokine expression not only in developing Th1 cells, but
also in otherwise irreversibly committed Th1 cells and
Th1 clones (3). GATA-3 fully reconstitutes Th2 develop-
ment in signal transducer and activator of transcription
(STAT)-6–deficient T cells (4). Furthermore, GATA-3 in-
hibits IFN-
 
  
 
production, probably through down-regulation
of STAT-4 expression (5).
However, the in vivo analysis of GATA-3 function
with regard to T cell differentiation is difficult as GATA-3
also plays an important role during vertebrate embryogen-
esis and homozygous mutant mice lacking GATA-3 do
not survive gestation (6). Moreover, RAG-2
 
 
 
/
 
  
 
C57BL/6
mice reconstituted with GATA-3
 
 
 
/
 
  
 
embryonic stem cells
do not develop T cells as GATA-3 is a critical transcrip-
tion factor for thymic T cell development (7). Thus, the
role of GATA-3 in T cell differentiation in vivo is still
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rather elusive. Moreover, the significance of GATA-3 in
regulating human T cell differentiation has not been addressed
in detail.
To delineate the in vivo role of GATA-3 in human T
cell differentiation we analyzed previously described indi-
viduals lacking one functional GATA-3 allele (GATA-3
 
 
 
/
 
 
 
;
references 8 and 9). We demonstrate that CD4 T cells from
GATA-3
 
 
 
/
 
  
 
individuals express decreased levels of GATA-3
associated with decreased Th2 cell frequencies in vivo and
in vitro and reduced Th2-dependent effector functions
in vivo. On the other hand, inhibition of GATA-3 by
GATA-3–specific small interfering RNA (siRNA) in con-
trol CD4 T cells (GATA-3
 
 
 
/
 
 
 
) resulted in dramatically re-
duced Th2 cell differentiation, emphasizing the significance
of GATA-3 in human Th2 cell development. Taken to-
gether, the data indicate that GATA-3 is critically involved
in regulating human Th2 cell differentiation.
 
Materials and Methods
 
Reagents and Antibodies.
 
The following mAbs and reagents
were used for purification, stimulation, and staining: anti-CD16
(3g8FcIII), anti-CD45RO (UCHT-1), anti-CD3 (OKT3), anti-
CD8 (OKT8), and anti–HLA-DR (L243; American Type Cul-
ture Collection); FITC-conjugated anti-CD3, PE-labeled anti-
CD4, and FITC-labeled anti-CD4 (Sigma-Aldrich); anti-CD19
and FITC-labeled anti–HLA-DR (DakoCytomation); PE-labeled
anti–IL-4 (MP4-25D2), FITC-labeled anti–IFN-
 
  
 
(4S.B3), and
anti-CD28 (CD28.2; BD Biosciences); polyclonal goat anti–
mouse Igs (ICN Biomedicals); anti-CD45RA (111-1C5; pro-
vided by R. Vilella, Hospital Clinic, Barcelona, Spain); human
recombinant IL-4 and neutralizing mAb to IL-4 (Endogen); hu-
man recombinant IL-12 (provided by the Genetics Institute); and
human recombinant IL-2 (GIBCO BRL).
 
Study Population.
 
Three individuals (a 16-yr-old male, an 18-
yr-old male, and a 30-yr-old female) in whom genetic abnormal-
ities in one GATA-3 allele have been identified (8–10) were ana-
lyzed in the study (see Table I). These individuals have normal
peripheral blood T cell and CD4 T cell counts. They do not have
any signs of immunological incompetence and have undergone
successful immunizations. GATA-3 haploinsufficiency was re-
ported in some tissues resulting clinically in hypoparathyroidism,
sensorineural deafness, and renal insufficiency (HDR syndrome;
reference 8). Young healthy volunteers of comparable age and
gender not taking any medications were used as control GATA-
3
 
 
 
/
 
  
 
individuals.
 
Determination of Ig Levels.
 
Serum Ig levels were determined
by standard ELISA procedures in the central clinical laboratory
facility of the University of Erlangen-Nuremberg. The normal
ranges are defined by the 2.5 and 97.5 percentiles of age-matched
healthy individuals.
 
Cell Purification.
 
CD4 naive or memory T cells were isolated
from peripheral blood of GATA-3
 
 
 
/
 
  
 
or control individuals by
negative selection using mAbs to CD8, CD19, CD16, HLA-DR,
CD45RO, or CD45RA as previously described (11, 12). Homo-
geneity and purity of the recovered cells were assessed by flow
cytometry.
 
Cell Cultures.
 
All cell cultures were performed in RPMI
1640 medium supplemented with 100 IU/ml penicillin G, 100
mg/ml streptomycin, 2 mM 
 
l
 
-glutamine (all GIBCO BRL),
10% normal human serum, and 10 U/ml recombinant human
IL-2. CD4 naive T cells were stimulated with 1 
 
 
 
g/
 
 
 
l immobi-
lized anti-CD3. For Th2-inducing conditions, 1 
 
 
 
g/
 
 
 
l anti-
CD28 and IL-4 (31.25 ng/ml, where indicated) were added.
For Th1-inducing conditions, 40 ng/ml IL-12 and 10 
 
 
 
g/
 
 
 
l
anti–IL-4 were added to the cell culture. CD4 memory cells
were primed under Th2-inducing conditions with 1 
 
 
 
g/
 
 
 
l
anti-CD28 in the presence or absence of 31.25 ng/ml IL-4 (12).
After 5 d cells were analyzed for cytokine mRNA by RT-PCR.
T cell effector functions were assessed after an additional 2.5 d
of rest.
 
siRNA Transfection.
 
Freshly isolated memory CD4 T cells
were transfected with 4 
 
 
 
M GATA-3 SMARTpool siRNA or,
as control, lamin siRNA (Dharmacon) using the human T cell
nucleofector kit (Amaxa) according to the manufacturer’s in-
structions. The transfection efficiency was close to 100% as as-
sessed by using FITC-labeled 30 mer oligos.
 
Intracellular Cytokine Analysis.
 
Cytoplasmic cytokine produc-
tion was determined by intracellular staining as previously de-
scribed (11). In brief, 2 
 
  
 
10
 
6 
 
cells were stimulated with 1 mM
ionomycin (Calbiochem) and 20 ng/ml PMA (Sigma-Aldrich)
for 5 h in the presence of 2 
 
 
 
M monensin (Sigma-Aldrich). Cells
were fixed with 4% paraformaldehyde (Sigma-Aldrich) and per-
meabilized with 0.1% (wt/vol) saponin (Sigma-Aldrich) in 2%
FCS/PBS (both GIBCO BRL). Nonspecific binding sites were
blocked with 4% mouse and rat serum. Cytoplasmic IL-4 and
IFN-
 
  
 
were detected by staining with directly labeled mAb
against human cytokines for 25 min on ice. Cells were washed
with 0.1% saponin/2% FCS/PBS, resuspended in 2% FCS/PBS,
and analyzed by flow cytometry. An aliquot of the cells were
stained with irrelevant mAbs as control for determining back-
ground fluorescence.
 
Western Blot Analysis.
 
2 
 
  
 
10
 
6 
 
cells were lysed in 20 
 
 
 
l 1
 
 
 
SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10%
glycerol, 50 mM DTT, 0.01% bromophenol blue). Proteins were
separated in a 10% SDS polyacrylamide gel and transferred onto
a nitrocellulose membrane (Schleicher & Schuell). The blots
were incubated with specific antibodies for GATA-3 (H48;
Santa Cruz Biotechnology, Inc.), STAT-6 (S20; Santa Cruz
Biotechnology, Inc.), and actin (Sigma-Aldrich), followed by
horseradish peroxidase–conjugated anti–rabbit Ig (New England
Biolabs, Inc.).
 
Preparation of Total RNA and RT-PCR.
 
Total RNA was ex-
tracted using the RNeasy Minikit (QIAGEN) with an additional
DNA digestion step (RNase Free DNase set; QIAGEN). RT
(TaqMan Reverse Transcription Reagent; Applied Biosystems)
was performed in a conventional thermocycler (10 min at 25
 
 
 
C,
40 min at 48
 
 
 
C, and 5 min at 95
 
 
 
C) with 1 
 
 
 
g total RNA in a 1:1
mixture of oligo(dT) and random hexamer primers in a final
volume of 20 
 
 
 
l. Real-time PCR was performed with the Light-
Cycler and the FastStart DNA Master SYBR Green I kit (Roche
Diagnostics). The primer sequences for GATA-3 and the house-
keeping gene EF-1-a were deduced from published sequences
(GATA-3: 5
 
 
 
-GAACCGGCCCCTCATTAAG-3
 
  
 
and 5
 
 
 
-ATT-
TTTCGGTTTCTGGTCTGGAT-3
 
 
 
, EF-1-a: 5
 
 
 
-GTTGATA-
TGGTTCCTGGCAAGC-3
 
  
 
and 5
 
 
 
-GCCAGCTCCAGCAG-
CCTTC-3
 
 
 
; reference 13). Data were evaluated using the Light-
Cycler software version 3.5.28 (Roche Diagnostics) and the sec-
ond derivative maximum algorithm. Specificity of the PCR
product was confirmed by agarose gel electrophoresis and melting
curve analysis. Serial dilutions of human CD4 cells were used to
generate the standard curves.
 
Statistical Analysis.
 
Differences in data distribution were ana-
lyzed by the two-tailed Student’s 
 
t
 
 test. 
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Results and Discussion
 
The Loss of One Functional GATA-3 Allele Results in Re-
duced Th2 Cell Differentiation and Decreased Th2 Effector Func-
tions In Vivo.
 
Indications of protein functions in vivo
have largely been derived from gene knockout approaches.
However, the analysis of proteins critically involved in em-
bryogenesis or early organ development is difficult to pur-
sue if the target disruption of the particular gene results in
the death of the embryo. To evaluate the role of GATA-3
in human Th2 cell differentiation in vivo, we analyzed
three individuals lacking one functional GATA-3 allele
(Table I). CD4 T cells from those individuals contained
significantly less GATA-3 protein than CD4 T cells from
controls (Fig. 1 A). Ex vivo analysis of cytokine production
by CD4 memory T cells from the peripheral blood of the
GATA-3
 
 
 
/
 
  
 
individuals revealed that the frequencies of
IL-4–producing Th2 cells were at the lower end of or be-
low the normal range (Fig. 1 B). In contrast, the frequen-
cies of IFN-
 
 
 
–producing Th1 cells were within the normal
range (Fig. 1 B). The decreased Th2 cell frequencies in the
peripheral blood of the GATA-3
 
 
 
/
 
  
 
individuals resulted in
a shift of the Th2/Th1 balance, reflecting a Th1 bias in
these individuals (Table II).
To assess T cell–mediated effector functions in vivo we
measured concentrations of different Ig classes and IgG sub-
classes in the serum. Although the levels of IgM and IgA
were within the normal range in all GATA-3
 
 
 
/
 
  
 
individu-
als, the levels of the Th2-dependent IgE were in the lower
range near the bottom of the normal limits (Fig. 1 D). In
contrast, the total IgG concentrations were within or above
the normal range (Fig. 1 E). Interestingly, although the con-
centrations of the Th1-dependent Ig, IgG1, were increased
in the serum of all GATA-3
 
 
 
/
 
  
 
individuals, the levels of the
Th2-dependent IgG4 were dramatically decreased (Fig. 1
E). The levels of IgG2 and IgG3 were distributed within the
normal limits (Fig. 1 E). Thus, these data indicate that the
reduction of the GATA-3 protein level in CD4 T cells in
vivo resulted in Th1-shifted CD4 T cell differentiation and
effector functions in humans. Moreover, this is the first con-
clusive demonstration that Th1-biased immunity in vivo in
humans is associated with increased levels of IgG1 and re-
duced production of IgE and IgG4.
 
CD4 T Cells Lacking One GATA-3 Allele Manifest Re-
duced Th2 Cell Differentiation In Vitro.
 
Next, we analyzed
the ability of CD4 T cells lacking one functional GATA-3
allele to differentiate into the Th2 direction in vitro. Naive
CD4 T cells were isolated from the peripheral blood of the
GATA-3
 
 
 
/
 
  
 
individuals and cultured under Th2-inducing
conditions. In accordance with the in vivo data, Th2 cell
differentiation from CD4 cells of the GATA-3
 
 
 
/
 
  
 
individ-
uals was less effective compared with the control group,
 
Table I.
 
GATA-3 Genetic Abnormalities in 
GATA-3
 
    
 
Individuals
 
Mutation Phenotype
Individual no. 1 49-bp intragenic
deletion
Frameshift,
premature stop codon
Individual no. 2 900-kb deletion Deletion of one allele
Individual no. 3 Terminal deletion of 
chromosome 10p Deletion of one allele
Figure 1. CD4 T cells from GATA-3 /  individuals
express reduced levels of GATA-3 associated with de-
creased Th2 cell differentiation and reduced Th2 effector
functions. (A) Whole cell lysates of CD4 T cells from
GATA-3 /  (individual no. 1) and GATA-3 /  (control)
individuals were analyzed by Western blotting with
mAbs to GATA-3 and actin. One representative of
three independent experiments with similar results is
shown. (B) Freshly isolated memory CD4 T cells from
GATA-3 /  individuals were stimulated in vitro with
PMA and ionomycin and analyzed for cytoplasmic
IL-4 (Th2) and IFN-  (Th1). Dots indicate Th2 and
Th1 cell frequencies of the individual GATA-3 / 
individuals, whereas the shaded areas denote mean  
SD of 20 age-matched control individuals. (C) Freshly
isolated naive T cells of GATA-3 /  individuals were
primed in vitro under Th2-inducing conditions, stimu-
lated with PMA and ionomycin, and assessed for cyto-
plasmic IL-4 and IFN- . Dots indicate Th2 and Th1
cell frequencies of two GATA-3 /  individuals. The
third GATA-3 /  individual was not analyzed because
of limited numbers of available cells. Shaded areas denote
the normal range of control individuals. (D and E) Serum
Ig levels of GATA-3 /  individuals. Shaded areas reflect
the normal limits. 
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whereas Th1 cell differentiation was increased (Fig. 1 C).
This resulted in a markedly decreased Th2/Th1 ratio when
compared with the control group (Table II). Therefore, re-
duced GATA-3 protein levels in human CD4 T cells di-
minishes the efficiency of Th2 cell differentiation in vitro
while favoring Th1 development.
Th1-dominated immunity has been implicated in the
immunopathology of several autoimmune diseases (14).
Moreover, impaired Th2 cell differentiation has been doc-
umented at the onset of autoimmune rheumatoid inflam-
mation and has been suggested to contribute to the devel-
opment of chronic unresolved Th1 inflammation (12).
However, despite the marked Th1 shift in the GATA-3
 
 
 
/
 
 
 
individuals, they did not manifest clinical signs of T cell–
mediated immunologic disorders at the time of analysis,
such as autoimmune diseases (9, 10). Furthermore, the sera
of the GATA-3
 
 
 
/
 
  
 
individuals were negative for autoanti-
bodies to kidney, adrenal gland, thyroid, parathyroid
gland, and the mucosa of the stomach, and for autoanti-
bodies to nuclear and mitochondrial antigens (not de-
picted). From the genetic point of view, induction of au-
toimmunity is a result of particular combinations of allelic
variants or DNA mutations that affect the expression/
function of genes involved in immune responses (15, 16).
However, most isolated mutations have an almost unde-
tectable effect with regard to autoimmunity and only in
combination with allelic variants of other loci do they re-
sult in an autoimmune phenotype (15). Therefore, al-
though GATA-3 is an important gene for directing the
immune response, the decrease of its expression level ap-
pears not to be sufficient to induce autoimmune disorders
in the genetic environment of the GATA-3
 
 
 
/
 
  
 
individuals
analyzed here.
The loss of one GATA-3 allele in humans results clinically
in hypoparathyroidism, sensorineural deafness, and renal in-
sufficiency (8). This raises the possibility that metabolic ab-
normalities caused by hypoparathyroidism and renal insuffi-
ciency might have affected lymphocyte responses in the
GATA-3
 
 
 
/
 
  
 
individuals. However, analysis of Th differenti-
ation in vivo and in vitro and of serum Ig levels in three
control patients with chronic renal insufficiency and in two
patients with hypoparathyroidism did not reveal any differ-
ences compared with GATA-3
 
 
 
/
 
   individuals (not de-
picted). These data strongly support the view that Th1-
shifted immunity in GATA-3 /  individuals is a conse-
quence of insufficient GATA-3 protein expression.
Silencing of GATA-3 by GATA-3–specific siRNA Results
in Impaired Th2 Cell Differentiation In Vitro. To substanti-
ate the important role of GATA-3 in human Th2 cell dif-
ferentiation in greater detail, we blocked GATA-3 expres-
sion by transfecting freshly isolated memory CD4 T cells
from GATA-3 /  control individuals with siRNA specific
for GATA-3. After 2 d of culture in the presence of non-
mitogenic concentrations of IL-2, the GATA-3 protein
level was assessed by Western blot analysis. Transfection of
memory CD4 T cells with GATA-3 siRNA resulted in a
markedly decreased level of GATA-3 protein when com-
pared with control siRNA (Fig. 2 A, lamin). In contrast,
the protein level of STAT-6, another transcription factor
important in Th2 cell differentiation, was not affected.
Priming of GATA-3 siRNA-transfected memory CD4 T
cells under conditions that were optimal for Th2 cell differ-
entiation from human memory cells (12, 17) resulted in
significantly reduced Th2 differentiation (Fig. 2 B), indicat-
ing a dominant role of GATA-3 in initiating the Th2 cell
differentiation program. Thus, the results are concordant
with the results from GATA-3 /  CD4 T cells.
Expression of GATA-3 Is Up-regulated During Human Th2
Cell Differentiation. In the mouse GATA-3 is expressed at
a high level during Th2 cell development (2). To analyze
GATA-3 expression during human Th2 cell differentia-
tion, CD4 naive T cells were isolated from GATA-3 / 
control individuals and cultured under Th2- or Th1-
inducing conditions for 5 d. GATA-3 mRNA levels were
assessed in the generated effector populations by highly
sensitive quantitative real-time PCR. A more than twofold
Table II. Th2/Th1 Ratioa
In Vivo In Vitrob
Control group 0.108   0.057 0.350   0.261
Individual no. 1 0.037 0.108
Individual no. 2 0.006 0.038
Individual no. 3 0.049 ND
aData are presented as absolute values or mean   SD.
bEffector cells were generated from naive CD4 T cells.
Figure 2. Silencing of GATA-3 inhibits human Th2 cell differentiation.
(A) Freshly isolated CD4 memory T cells from GATA-3 /  individuals
were transfected with siRNA specific for GATA-3 or lamin (control),
and GATA-3, actin, and STAT-6 protein levels were assessed 2 d later by
Western blot analysis. GATA-3 protein levels were assessed by densito-
metric analysis after Western blot and normalized for actin. (B) After
transfection, freshly isolated memory T cells from GATA-3 /  individuals
were cultured under Th2-inducing conditions. For control, untransfected
cells were analyzed after priming in neutral (non-Th1/Th2–inducing)
conditions (medium). Cytoplasmic IL-4 was determined in the generated
effector populations as described in Materials and Methods. Data from
five independent experiments with cells from individual donors are indi-
cated by dots and connected with lines.Skapenko et al. Brief Definitive Report 427
increase of the GATA-3 mRNA level was observed in cells
primed with anti-CD3 and CD28 mAbs (Th2-inducing
conditions) when compared with cells primed with anti-
CD3 mAb alone (neutral conditions; Fig. 3 A). A further
increase was induced when IL-4 was added to the priming
culture (Fig. 3 A). In contrast, Th1-inducing conditions re-
sulted in marked reduction of the GATA-3 mRNA level
(Fig. 3 A). The levels of the GATA-3 mRNA correlated
with the Th2 cell frequencies in the respective populations
as assessed by flow cytometric analysis of cytoplasmic IL-4
(Fig. 3 A). An increase in the GATA-3 mRNA level was
also observed during Th2 cell differentiation from human
memory CD4 cells (Fig. 3 B). Thus, human Th2 cell dif-
ferentiation is accompanied by an increase in the GATA-3
mRNA level. As a consequence, the significant increase in
GATA-3 mRNA during human Th2 cell differentiation
resulted in increased GATA-3 protein levels in sorted IL-
4–producing Th2 cells when compared with IFN- –pro-
ducing Th1 cells (Fig. 3 C). Of interest, Th1 cells expressed
a relatively high level of GATA-3 protein, which was not
anticipated. Whether this relates to an important function
of GATA-3 in maintaining T cell–specific transcriptional
regulation as reported previously (13, 18, 19) or to a low
turnover of GATA-3 protein remains to be elucidated.
The identification of Th2-specific transcription factors
that control the production of IL-4 and, hence, the contin-
ued formation of Th2 cells might allow a selective manipu-
lation of Th subsets, for example in human diseases that are
characterized by unbalanced Th cell differentiation, such as
autoimmune diseases or allergies. The determination of
whether these transcription factors are also involved in reg-
ulating Th2 development in human cells is a first step to
evaluate such a possibility. Using the unique opportunity to
evaluate GATA-3 /  individuals and using diverse in vitro
assays we could for the first time conclusively demonstrate
an important role of the transcription factor GATA-3 in
human Th2 cell differentiation. As significantly reduced
levels of GATA-3 expressed in CD4 T cells of GATA-3 / 
individuals resulted in decreased Th2 cell differentiation
in vivo and in vitro associated with markedly diminished
Th2 cell–mediated effector functions in vivo, targeting
GATA-3 might be a successful means to modulate inap-
propriate Th2 effector functions.
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